Advances in Metastatic Breast Cancer Care: Guidance on Antibody–Drug Conjugate Therapy for the Community Multidisciplinary Team
Download this regularly updated slideset for expert insights on incorporating antibody–drug conjugates into community care of metastatic breast cancer, including patient selection, deciding among agents, and managing toxicities.
Professor of Medicine Head Division of Hematology and Oncology Department of Medicine UW Medicine Senior Vice President Clinical Research Division Fred Hutchinson Cancer Center Seattle, Washington
Sara M. Tolaney, MD, MPH
Assistant Professor of Medicine Harvard Medical School Associate Director Susan F. Smith Center for Women’s Cancers Director Clinical Trials, Breast Oncology Director Breast Immunotherapy Clinical Research Dana-Farber Cancer Institute Boston, Massachusetts
Supported by educational grants from AstraZeneca; Daiichi Sankyo, Inc.; and Gilead Sciences, Inc.
Daiichi Sankyo, Inc.
Gilead Sciences, Inc.
Select date of attendance
Welcome to the CCO site
Thank you for your interest in CCO content. As a guest, please complete the following information. This data helps ensure our continued delivery of impactful medical education.
You will be sent to the previous page if you close this window.